Clinical Trial Update: SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI

View source ↗

Summary

SCIVAX is a clinical trial investigating biomarkers of immune dysfunction and vaccine responsiveness in chronic spinal cord injury. The study is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Snippet

Sponsor: Northwell Health | Conditions: Spinal Cord Injuries, Traumatic Spinal Cord Injury | Status: ACTIVE_NOT_RECRUITING